Scott Wolchko, President & CEO, Director at Fate Therapeutics, holds 371.25K shares in Fate Therapeutics (Ticker: FATE). Most recently, Scott Wolchko Sold $14,391 shares of Fate Therapeutics on Jan 10, 2024 for an estimated value of 62.89K.
What is the percentage of profitable transactions made by Scott Wolchko?
The percentage of profitable transactions made by Scott Wolchko is 56%.
What is the average return per transaction made by Scott Wolchko?
The average return per transaction made by Scott Wolchko is -31.40%.
What stocks does Scott Wolchko hold?
Scott Wolchko holds: FATE stocks.
What was Scott Wolchko’s latest transaction?
Scott Wolchko latest transaction was an Informative Sell of $62.89K.
What was Scott Wolchko's most profitable transaction?
Scott Wolchko’s most profitable transaction was an Informative Sell of FATE stock on January 13, 2022. The return on the trade was 87.20%.
What is Scott Wolchko's role in Fate Therapeutics?
Scott Wolchko's role in Fate Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.